Upregulation of Mif expression has been implicated in the activation of microglial‐mediated inflammatory processes and has recently been proposed to be a biomarker of Alzheimer’s disease (Zhang et al, 2016, 2019). This evidence concerns the gene MIF and Alzheimer disease.